1-4 of 4
Kevin R. Viel, PhD
Close
Sort by
Journal Articles

A Novel Biomarker for Inhibitor Risk Prediction-the HLA-II Bound and Unbound Components of FVIII Derived Peptides-Reveals a Protective Influence for N-Linked Glycosylation

Kevin R. Viel, PhD, Marco Hofmann, MD PhD, Sabine Zollner, Bernadette W. Luu, Rajalingam Raja, PhD, Jerry Sherman Powell, MD, Eugene Maraskovsky, MD, PhD, Tom E. Howard, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2292.
https://doi.org/10.1182/blood.V126.23.2292.2292
Published: 2015
Journal Articles

The Spectrum of Amino Acid Substitutions Resulting from Single Nucleotide Substitutions in the Coagulation Biosystem: Impact on Identification By Mass Spectrometry

Kevin R. Viel, PhD, Benjamin Kim, MD MPhil, Maria Elizabeth Tejero, PhD, Shelley S. Cole, PhD, Tom E. Howard, MD PhD, Amparo Santamaría Ortiz, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 4221.
https://doi.org/10.1182/blood.V124.21.4221.4221
Published: 2014
Journal Articles

Heritability of Commonly Measured Blood Cell Phenotypes in the San Antonio Family Heart Study.

Kevin R. Viel, PhD, Tom Howard, PhD, MD, Joanne E. Curran, PhD, Laura Almasy, PhD, Eric K. Moses, PhD, David C. Glahn, PhD, Afshin Ameri, MD, Blangero John, PhD
Journal: Blood
Blood (2007) 110 (11): 3687.
https://doi.org/10.1182/blood.V110.11.3687.3687
Published: 2007
Journal Articles

The Pharmacogenetics and Inhibitor Risk (PIR) Study: Establishing the Spectrum of Factor (F)VIII Gene (F8) Mutations in African-American Hemophilia A Patients.

Tom E. Howard, MD, PhD, Deepa K. Machiah, BS, Kevin R. Viel, PhD, Cynthia Channel, BS, Afshin Ameri, MD, Rathi V. Iyer, MD, Ray G. Watts, MD, Charles Lutcher, MD, Joanna Davis, MD, Thomas C. Abshire, MD, Laura Almasy, PhD
Journal: Blood
Blood (2005) 106 (11): 3207.
https://doi.org/10.1182/blood.V106.11.3207.3207
Published: 2005